Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
BTLA VHH recombinant monoclonal antibody
C1S VHH recombinant monoclonal antibody
C5AR1 VHH recombinant monoclonal antibody
CA125 VHH recombinant monoclonal antibody
CA9 VHH recombinant monoclonal antibody
CALCRL VHH recombinant monoclonal antibody
CCL2 VHH recombinant monoclonal antibody
CCR2 VHH recombinant monoclonal antibody
CCR4 VHH recombinant monoclonal antibody
CCR5 VHH recombinant monoclonal antibody